An international, peer reviewed, open access journal that aims to support those engaged in research on biomarkers and cancer, by providing rapid communication of the latest advances in the application of biomarkers toward discovery of new knowledge and clinical application of that knowledge.
Editor in Chief: Dr. Barbara Guinn
Processing Speed: High quality, constructive peer review and rapid editorial decision within an average of four weeks.
Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer
As Editor-in-Chief of Biomarkers in Cancer I wanted to know what it is like to publish in my own journal. I have already published over 70 papers, so I knew what a range of other journals were like. I was impressed by the quality of the reviewers comments which made the paper so much better before it was accepted for publication. I was pleasantly surprised by how quickly the article went from acceptance to published, ...